LONDONShares in British biotech group Proteome Sciences PLC rose sharply Tuesday after the company made what it called a significant step toward developing a blood test for Alzheimers In a study cowritten with researchers from Kings College London the company said it has identified a set of  proteins in blood that can predict the onset of Alzheimers the most common form of dementia  There
  